Home/ Supplements/ Phosphorus/ Soy Lecithin Granules

Soy Lecithin Granules

product on market Powder PL Progressive Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 23% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains basic macronutrients and minerals, including calcium and phosphorus, which are essential for bone health and cellular function. Research provides strong evidence for the physiological roles of these minerals in the human body. However, overall evidence coverage for this specific ingredient profile is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Soy Lecithin Granules
Open Full PDF View on NIH DSLD →
Details

Label Data

7 Gram(s)
Serving Size
65
Servings
Other Combinations
Product Type
23%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
49 Calorie(s)
Total Fat
3.7 Gram(s) (6% DV)
Total Carbohydrates
0.6 Gram(s) (1% DV)
Calcium
10 mg (1% DV)
210 mg (21% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:3)
Potassium
84 mg (2% DV)
Total Phosphatides
6.8 Gram(s)
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
Phosphatidyl Ethanolamine
1.4 Gram(s)
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Phosphatidyl Serine
280 mg
Phytoglycolipids
900 mg
Other Phosphatides
1.4 Gram(s)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: One tablespoon may be added to cereal, soup, or mixed into gravies, meatloaf, hamburgers, etc. It will also add a delicious flavor to your favorite milkshake or vegetable juice cocktail.

Warnings & Precautions

Tamper evident seals around cap and on bottle. Do not use if either seal is broken or missing.

Keep out of reach of children.

Formulation Notes

Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)

Excellent source of Choline

Additional Information

Sold only for dispensing by a licensed health care professional.

Store in a cool, dry place, tightly closed.

GMP 3rd party confirmed compliant

Metadata

Product Details

UPC / SKU3 51821 00923 0
DSLD Entry Date2022-06-16
Product TypeOther Combinations
FormPowder
DSLD ID263164
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.